Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP259499.RAFFd3WZ3Y21DyMot_oXvGwmmBABgFgR6TP4MAJzrfvcg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP259499.RAFFd3WZ3Y21DyMot_oXvGwmmBABgFgR6TP4MAJzrfvcg130_assertion type Assertion NP259499.RAFFd3WZ3Y21DyMot_oXvGwmmBABgFgR6TP4MAJzrfvcg130_head.
- NP259499.RAFFd3WZ3Y21DyMot_oXvGwmmBABgFgR6TP4MAJzrfvcg130_assertion description "[Additionally, the protein levels of G1 acting cyclin-dependent kinases (CDKs), CDK2, 4 and 6, was unaltered in Tam-treated lung cancer cells with the exception of CDK2 expression in H322 cells which was attenuated by Tam in a cell line-specific manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP259499.RAFFd3WZ3Y21DyMot_oXvGwmmBABgFgR6TP4MAJzrfvcg130_provenance.
- NP259499.RAFFd3WZ3Y21DyMot_oXvGwmmBABgFgR6TP4MAJzrfvcg130_assertion evidence source_evidence_literature NP259499.RAFFd3WZ3Y21DyMot_oXvGwmmBABgFgR6TP4MAJzrfvcg130_provenance.
- NP259499.RAFFd3WZ3Y21DyMot_oXvGwmmBABgFgR6TP4MAJzrfvcg130_assertion SIO_000772 10435640 NP259499.RAFFd3WZ3Y21DyMot_oXvGwmmBABgFgR6TP4MAJzrfvcg130_provenance.
- NP259499.RAFFd3WZ3Y21DyMot_oXvGwmmBABgFgR6TP4MAJzrfvcg130_assertion wasDerivedFrom befree-2016 NP259499.RAFFd3WZ3Y21DyMot_oXvGwmmBABgFgR6TP4MAJzrfvcg130_provenance.
- NP259499.RAFFd3WZ3Y21DyMot_oXvGwmmBABgFgR6TP4MAJzrfvcg130_assertion wasGeneratedBy ECO_0000203 NP259499.RAFFd3WZ3Y21DyMot_oXvGwmmBABgFgR6TP4MAJzrfvcg130_provenance.